Skip to main content

Table 1 Clinical symptoms, laboratory examinations, imaging findings, and outcomes in both groups

From: Case-controlled study of tuberculosis in in-vitro fertilisation-embryo transfer and natural pregnancy

 

IVF-ET conception group

(n=13)

Natural conception group

(n=37)

P

Clinical symptoms

   

Fever

12(92.31)

15(40.54)

0.001

Cough and expectoration

5(38.46)

22(59.46)

0.19

Hemoptysis

0(0)

6(16.22)

0.293

Pectoralgia

0(0)

6(16.22)

0.293

Dyspnea

2(15.38)

4(10.81)

0.66

Positive tuberculosis etiology

4(30.77)

16(43.24)

0.143

Combined with hematogenous disseminated tuberculosis

12(92.31)

6(16.22)

0.000

Combined with extrapulmonary tuberculosis

10(76.92)

10(27.03)

0.002

Termination of pregnancy

11(84.62)

18(48.65)

0.024

Gestational age for screening (week)

19.15 ± 4.24

21.18 ± 11.18

0.544

Gestational age for termination (week)

14.89 ± 8.12

19.6 ± 4.55

0.104

  1. Note: IVF-ET in-vitro fertilisation and embryo transfer